Trial Profile
Safety and Dose Finding Study of Different MOD-4023 Dose Levels Compared to Daily R-human Growth Hormone (hGH) Therapy in Pre-pubertal Growth Hormone Deficient Children
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Therapeutic Use
- Sponsors OPKO Health
- 06 Feb 2024 Status changed from active, no longer recruiting to completed.
- 18 Jun 2023 Results assessing long term efficacy and safety of somatrogon in pGHD presented at the 105th Annual Meeting of the Endocrine Society
- 18 Apr 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.